This website will offer limited functionality in this browser. We only support the recent versions of major browsers like Chrome, Firefox, Safari, and Edge.
Tim Wilsdon is a panelist during the session titled “Access to Oncology Combinations – the ‘Combination Challenge.'”
Michele Pistollato is presenting two posters during the conference. The first explores novel evidence on the consequences of increased net price transparency in Europe. The second looks at the challenges bringing oncology combinations to market, and their solutions. Both research projects were funded by MSD.
For more information on this event, click here.
Access to medicine and healthcare services poses persistent challenges, especially in low-income regions with high out-of-pocket expenses. Pharmaceutical...
Newborn screening (NBS) has become an integral part of many public health programs.1 NBS programs have minimized patient suffering which results from extended...
Join us for a CRA-moderated panel discussion with leaders in Digital Therapeutics. Learn how key players are reacting to emerging challenges, and which...
CRA is exhibiting at the conference at booth #2018. Matt Majewski presents his session titled “What is a Fair Price for a Rare Disease Therapy?”...
